Page last updated: 2024-10-25

ciprofibrate and Hepatocellular Carcinoma

ciprofibrate has been researched along with Hepatocellular Carcinoma in 6 studies

Research Excerpts

ExcerptRelevanceReference
"Alterations in DNA ploidy accompany hepatocellular carcinoma (HCC)."5.29Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat. ( Goolsby, CL; Rao, MS, 1996)
"Ciprofibrate was more toxic to Fao cells than to MH1C1 and HepG2 cells which is also the order of the acyl-CoA oxidase stimulation by ciprofibrate."1.29Stimulation of peroxisomal palmitoyl-CoA oxidase activity by ciprofibrate in hepatic cell lines: comparative studies in Fao, MH1C1 and HepG2 cells. ( Bournot, P; Brocard, C; Es-Souni, M; Latruffe, N; Ramirez, LC, 1993)
"Alterations in DNA ploidy accompany hepatocellular carcinoma (HCC)."1.29Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat. ( Goolsby, CL; Rao, MS, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyer, K1
Lee, JS1
Dyck, PA1
Cao, WQ1
Rao, MS2
Thorgeirsson, SS1
Reddy, JK2
Chung, C1
Doll, JA1
Stellmach, VM1
Gonzales, J1
Surapureddi, S1
Cornwell, M1
Crawford, SE1
Brocard, C1
Es-Souni, M1
Ramirez, LC1
Latruffe, N2
Bournot, P1
Goolsby, CL1
Passilly, P1
Jannin, B1
Hassell, SJ1
Herbert, JM1
Bernat, A1
Chatenet-Duchène, L1

Other Studies

6 other studies available for ciprofibrate and Hepatocellular Carcinoma

ArticleYear
Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
    Carcinogenesis, 2003, Volume: 24, Issue:5

    Topics: Acyl Coenzyme A; Acyl-CoA Oxidase; Animals; Biomarkers, Tumor; Blotting, Northern; Carcinoma, Hepato

2003
Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha.
    Advances in experimental medicine and biology, 2008, Volume: 617

    Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Movement; Chromans; Clofibric Acid; Endothelium, Vascu

2008
Stimulation of peroxisomal palmitoyl-CoA oxidase activity by ciprofibrate in hepatic cell lines: comparative studies in Fao, MH1C1 and HepG2 cells.
    Biology of the cell, 1993, Volume: 77, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Clofibric Acid; Fibric Acids; Humans; Hypolipidemic Agents; Live

1993
Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat.
    British journal of cancer, 1996, Volume: 73, Issue:2

    Topics: Aneuploidy; Animals; Carcinoma, Hepatocellular; Clofibric Acid; DNA, Neoplasm; Fibric Acids; Flow Cy

1996
Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
    Experimental cell research, 1996, Mar-15, Volume: 223, Issue:2

    Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cell Size; Clofibric Acid; Cytoplasmi

1996
Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:5

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Clofibric Acid; Dose-Response Relationshi

1999